Suite of proprietary small molecule

 Id-protein antagonists.

 

These molecules show extensive in-vitro and in-vivo activity in oncology and vascular diseases of the eye.

Patents

Id-Protein Molecular Structure

with Target Crevice

© 2017 Angiogenex. All rights reserved.